1. Home
  2. NAMS vs STNG Comparison

NAMS vs STNG Comparison

Compare NAMS & STNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • STNG
  • Stock Information
  • Founded
  • NAMS 2019
  • STNG 2009
  • Country
  • NAMS Netherlands
  • STNG Monaco
  • Employees
  • NAMS N/A
  • STNG N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • STNG Marine Transportation
  • Sector
  • NAMS Health Care
  • STNG Consumer Discretionary
  • Exchange
  • NAMS Nasdaq
  • STNG Nasdaq
  • Market Cap
  • NAMS 2.5B
  • STNG 2.2B
  • IPO Year
  • NAMS N/A
  • STNG 2010
  • Fundamental
  • Price
  • NAMS $23.60
  • STNG $44.07
  • Analyst Decision
  • NAMS Strong Buy
  • STNG Buy
  • Analyst Count
  • NAMS 9
  • STNG 4
  • Target Price
  • NAMS $41.11
  • STNG $60.50
  • AVG Volume (30 Days)
  • NAMS 844.8K
  • STNG 1.4M
  • Earning Date
  • NAMS 08-06-2025
  • STNG 07-30-2025
  • Dividend Yield
  • NAMS N/A
  • STNG 3.61%
  • EPS Growth
  • NAMS N/A
  • STNG N/A
  • EPS
  • NAMS N/A
  • STNG 10.31
  • Revenue
  • NAMS $47,140,000.00
  • STNG $1,066,599,000.00
  • Revenue This Year
  • NAMS N/A
  • STNG N/A
  • Revenue Next Year
  • NAMS N/A
  • STNG $1.45
  • P/E Ratio
  • NAMS N/A
  • STNG $4.33
  • Revenue Growth
  • NAMS 586.97
  • STNG N/A
  • 52 Week Low
  • NAMS $14.06
  • STNG $30.63
  • 52 Week High
  • NAMS $27.29
  • STNG $77.83
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 67.01
  • STNG 54.98
  • Support Level
  • NAMS $22.00
  • STNG $42.54
  • Resistance Level
  • NAMS $24.82
  • STNG $45.29
  • Average True Range (ATR)
  • NAMS 1.21
  • STNG 1.80
  • MACD
  • NAMS 0.25
  • STNG -0.01
  • Stochastic Oscillator
  • NAMS 77.98
  • STNG 48.77

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About STNG Scorpio Tankers Inc.

Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.

Share on Social Networks: